Effectiveness Of Respiratory Syncytial Virus Immunoprophylaxis On Bronchiolitis Hospitalization Among High-Risk Infants

被引:0
|
作者
Wu, P. [1 ]
Escobar, G. J. [2 ]
Gebretsadik, T. [3 ]
Carroll, K. [1 ]
Li, S. [2 ]
Walsh, E. [2 ]
Mitchel, E. [1 ]
Sloan, C. [4 ]
Dupont, W. [3 ]
Yu, C. [3 ]
Hartert, T. V. [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Kaiser Permanente Northern Calif, Oakland, CA USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Brigham Young Univ, Provo, UT 84602 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A3029
引用
收藏
页数:1
相关论文
共 50 条
  • [31] THE RESPONSE OF INFANTS WITH BRONCHIOLITIS TO THE PROTEINS OF RESPIRATORY SYNCYTIAL VIRUS
    LEVINE, S
    DAJANI, A
    KLAIBERFRANCO, R
    JOURNAL OF GENERAL VIROLOGY, 1988, 69 : 1229 - 1239
  • [32] Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children
    Viguria, Natividad
    Navascues, Ana
    Juanbeltz, Regina
    Echeverria, Alberto
    Ezpeleta, Carmen
    Castilla, Jesus
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (06) : 1867 - 1872
  • [33] PATHOGENESIS OF RESPIRATORY SYNCYTIAL (RS) VIRUS BRONCHIOLITIS IN INFANTS
    GLEZEN, WP
    PAREDES, A
    TABER, LH
    PEDIATRIC RESEARCH, 1978, 12 (04) : 492 - 492
  • [34] Survey of pediatric ward hospitalization due to respiratory syncytial virus infection after the introduction of palivizumab to high-risk infants in Japan
    Kusuda, Satoshi
    Takahashi, Naoto
    Saitoh, Takami
    Terai, Masaru
    Kaneda, Hisashi
    Kato, Yuichi
    Ohashi, Atsushi
    Watabe, Shinichi
    Joh-o, Kunitaka
    Hirai, Katsuki
    PEDIATRICS INTERNATIONAL, 2011, 53 (03) : 368 - 373
  • [35] Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis
    Connor, E
    Top, F
    Kramer, A
    Schneider, M
    Love, J
    Carlin, D
    Siber, G
    Leszczynski, J
    McIver, J
    Hemming, V
    Henson, S
    Spruill, S
    Colven, C
    Wittes, J
    Vidyasagar, D
    Park, L
    Modlin, JF
    Rhodes, T
    Pramanik, AK
    Jue, S
    Smith, M
    Rabalais, GP
    Franco, S
    Wilkerson, S
    Bibb, K
    Pichoff, BE
    Remich, S
    Rettke, M
    Weisman, LE
    McDonald, MC
    Johnson, KE
    Adams, K
    Chartrand, SA
    Wilson, MC
    Redding, GJ
    Mayock, D
    Hanna, HJS
    Stevenson, DK
    Ariagno, RL
    Adams, MM
    Modler, S
    Subramanian, S
    Smith, YA
    Hoy, DA
    Kunos, I
    Angelus, P
    Yogev, R
    Davis, M
    Millard, DD
    Steichen, JJ
    PEDIATRICS, 1997, 99 (01) : 93 - 99
  • [36] EFFICACY OF RIBAVIRIN FOR TREATING RESPIRATORY SYNCYTIAL VIRUS (RSV) PNEUMONIA IN HIGH-RISK INFANTS
    SPINELLI, M
    GERACICIARDULLO, K
    PALUMBO, PE
    LASKIN, O
    EDELSON, PJ
    PEDIATRIC RESEARCH, 1985, 19 (04) : A304 - A304
  • [37] Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants: A note of caution
    Suresh, S
    Schilling, S
    Dakin, C
    Harris, MA
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2003, 39 (08) : 637 - 637
  • [38] Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain
    Cilla, G.
    Sarasua, A.
    Montes, M.
    Arostegui, N.
    Vicente, D.
    Perez-Yarza, E.
    Perez-Trallero, E.
    EPIDEMIOLOGY AND INFECTION, 2006, 134 (03): : 506 - 513
  • [39] Current and emerging pharmacological treatments for respiratory syncytial virus infection in high-risk infants
    Soto, Jorge A.
    Loaiza, Ricardo A.
    Echeverria, Sebastian
    Ramirez, Robinson A.
    Kalergis, Alexis M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (10) : 1143 - 1158
  • [40] Respiratory syncytial virus (RSV) bronchiolitis evokes a blunted immunoresponse in preterm (PT) infants requiring hospitalization
    Assefa, D
    Doshi, N
    Godi, I
    Amin, N
    Dozor, AJ
    Parton, LA
    PEDIATRIC RESEARCH, 2004, 55 (04) : 597A - 597A